Clinical evaluation of Malaria rapid antigen test

Clinical evaluation of Malaria rapid diagnostic test kits

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

PACTR

Registry ID

PACTR202407803149023

Enrollment

2000

Registered

2024-07-29

Start date

2024-07-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malaria

Interventions

STANDARD Q hs Malaria RDT

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Presenting at the study site with fever or a history of fever during the preceding 48-hours Freely agreeing to participate by providing informed consent (and assent, as applicable

Exclusion criteria

Exclusion criteria: Presence of symptoms and signs of severe illness and/or central nervous system infections as defined by WHO guidelines.

Design outcomes

Primary

Measure	Time frame
Relative diagnostic sensitivity and specificity shall be determined for each claimed specimen type.	—

Secondary

Measure	Time frame
RDT positivity rate	—

Countries

Ghana

Contacts

Public ContactBaafour Gyewu

Country representative

baafuor.gyewu@codixgroup.com+233267768730

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026